Index of reports
> Cases with Platelet Count Decreased (114)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Pegasys (Peginterferon Alfa-2A) where reactions include platelet count decreased. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 114 Next >>
Possible Pegasys side effects in female
Reported by a physician from Turkey on 2012-08-24
Patient: female, weighing 58.0 kg (127.6 pounds)
Reactions: Anaemia, Platelet Count Decreased, Leukopenia
Drug(s) suspected as cause:
Copegus
Dosage: dosage form: unknown
Indication: Hepatitis C
Pegasys
Dosage: dosage form: unspecified
Indication: Hepatitis C
VX-950
Dosage: dosage form: tablet, 3 times as two tablet
Administration route: Oral
Indication: Hepatitis C
Possible Pegasys side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-24
Patient: female, weighing 45.0 kg (99.0 pounds)
Reactions: Periorbital Oedema, Syncope, Anaemia, Platelet Count Decreased, Dizziness, Rash, Asthenia
Drug(s) suspected as cause:
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2012-06-05
Pegasys
Dosage: 90 a?g/kg, unk
Ribavirin
Dosage: 200 mg, qd
Start date: 2012-08-08
Ribavirin
Dosage: 600 mg, unk
Administration route: Oral
Start date: 2012-06-05
VX-950
Dosage: 750 mg, tid
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-05
Other drugs received by patient: Vitamin E BAR; Hydroxyzine HCL; Escitalopram; Femring MIS; Vitamin D; Progesterone; Lexapro; Ascorbic Acid
Possible Pegasys side effects in
Reported by a consumer/non-health professional from United States on 2012-08-22
Patient:
Reactions: White Blood Cell Count Decreased, Nausea, Insomnia, Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
Boceprevir
Dosage: 800 mg, tid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Pegasys
Dosage: 180 mg, unknown
Indication: Product Used FOR Unknown Indication
Ribasphere
Dosage: 3 df, qd
Ribasphere
Dosage: 600 mg, unknown
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Tamsulosin Hydrochloride; Hydroxyzine Hydrochloride; Proscar; Eltrombopag Olamine; Multamin; Propranolol Hydrochloride; Prilosec
Possible Pegasys side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-21
Patient: male
Reactions: Vomiting, Pneumonia, Swelling Face, Haemorrhage, Anaemia, Bone Swelling, Ill-Defined Disorder, Platelet Count Decreased, Fluid Retention
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Indication: Hepatitis C
Start date: 2012-05-23
Pegasys
Indication: Hepatitis C
Start date: 2012-05-23
Telaprevir
Indication: Hepatitis C
Start date: 2012-05-23
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-15
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Dosage: 180 microgram, qw
Pegasys
Dosage: 90 microgram, qw
Ribasphere
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-01
Other drugs received by patient: Procrit; Chloroquine Phosphate
Possible Pegasys side effects in
Reported by a physician from China on 2012-08-13
Patient:
Reactions: White Blood Cell Count Decreased, Hepatitis C, Drug Ineffective, Anaemia, Pyrexia, Myalgia, Platelet Count Decreased, Hypothyroidism, Asthenia
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Ribavirin (Non-Roche / NON-Comparator)
Dosage: 800-1200mg/d
Administration route: Oral
Indication: Hepatitis C
Possible Pegasys side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-13
Patient: male
Reactions: Haemorrhage Urinary Tract, Anaemia, Presyncope, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2012-06-01
Ribavirin
Indication: Hepatitis C
Start date: 2012-06-01
Telaprevir
Indication: Hepatitis C
Start date: 2012-06-01
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Basedow's Disease, Weight Decreased, Pruritus, Diabetes Mellitus, Rectal Haemorrhage, Blood Count Abnormal, Appetite Disorder, RED Blood Cell Count Decreased, Anorectal Discomfort, Oedema Peripheral, White Blood Cell Count Decreased, Faeces Hard, Dysgeusia, Mental Impairment, Diarrhoea, Disease Recurrence, Alopecia, Platelet Count Decreased, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Pegasys
Dosage: unk
Indication: Hepatitis C
Start date: 2005-04-01
End date: 2006-03-03
Pegasys
Dosage: unk
Start date: 2012-03-22
Rebetol
Dosage: unk
Indication: Hepatitis C
Start date: 2002-01-04
Rebetol
Dosage: 3 df, qd
Start date: 2012-03-22
Rebetol
Dosage: unk
Start date: 2005-04-01
End date: 2006-03-03
Victrelis
Dosage: unk
Indication: Hepatitis C
Start date: 2012-04-19
Possible Pegasys side effects in
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient:
Reactions: Dysgeusia, White Blood Cell Count Decreased, Pruritus, Diarrhoea, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Ribavirin
Dosage: 400 mg, unk
Victrelis
Dosage: 4 df (800 mg) tid,every 7-9 hours
Administration route: Oral
Other drugs received by patient: Omega-3-Acid Ethyl Esters; Vitamins (Unspecified)
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: Weight Decreased, Tinnitus, Chapped Lips, Oropharyngeal Pain, Fatigue, RED Blood Cell Count Decreased, Sinusitis, Back Pain, White Blood Cell Count Decreased, Pneumonia, Dysphagia, Stomatitis, Middle Ear Effusion, Anaemia, Pancytopenia, Rash, LIP Ulceration, Sensory Disturbance, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Copegus
Pegasys
Victrelis
Dosage: 4 df, tid
Other drugs received by patient: Ativan; Accolate; Lexapro; Proair (Albuterol Sulfate); Fluticasone Propionate; Procardia XL
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10
Patient:
Reactions: White Blood Cell Count Decreased, RED Blood Cell Count Decreased, Platelet Count Decreased, Menorrhagia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Rebetol
Administration route: Oral
Victrelis
Administration route: Oral
Possible Pegasys side effects in male
Reported by a physician from China on 2012-08-07
Patient: male
Reactions: White Blood Cell Count Decreased, Portal Hypertension, Hepatic Lesion, Gastritis Haemorrhagic, Anxiety, Hepatomegaly, Gamma-Glutamyltransferase Increased, Hepatic Cyst, Platelet Count Decreased, Neutrophil Count Decreased, Splenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Other drugs received by patient: Leucogen (Unk Ingredients); Glycyrrhizin; Thymopeptide; Chinese Patent Medicine (Unk Ingredients); Chinese Traditional Medicine
Possible Pegasys side effects in
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Rebetol
Victrelis
Dosage: 800 mg, tid (every 7-9 hours with food)
Administration route: Oral
Other drugs received by patient: Bupropion Hydrochloride; Minerals (Unspecified); Vitamins (Unspecified); Ascorbic Acid
Possible Pegasys side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: male, weighing 90.3 kg (198.8 pounds)
Reactions: Pruritus, Head Injury, Eczema, Fall, Fatigue, Skin Ulcer, Basal Cell Carcinoma, Thrombocytopenia, Skeletal Injury, Decreased Appetite, Rash Generalised, Skin Disorder, Hypotonia, Blood Disorder, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased, Respiratory Tract Infection
Drug(s) suspected as cause:
Pegasys
Start date: 2012-04-01
Pegasys
Start date: 2011-08-03
End date: 2012-06-01
Pegasys
Indication: Hepatitis C
Start date: 2011-08-03
End date: 2012-07-01
Pegasys
Indication: HIV Infection
Start date: 2011-11-02
Pegasys
Start date: 2011-03-08
End date: 2012-01-06
Ribavirin
Administration route: Oral
Start date: 2011-08-03
End date: 2012-06-01
Ribavirin
Administration route: Oral
Start date: 2011-11-02
Ribavirin
Dosage: in divided doses
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-03
End date: 2012-07-01
Trazodone HCL
Trazodone HCL
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Fenofibrate; Truvada; Gabapentin; Lexapro; Lipitor; Zofran; Lomotil; Trazodone Hydrochloride; Reyataz
Possible Pegasys side effects in female
Reported by a consumer/non-health professional from United States on 2012-08-07
Patient: female, weighing 105.3 kg (231.7 pounds)
Reactions: Weight Decreased, Folliculitis, Visual Acuity Reduced, Cyst, Photopsia, Menstruation Irregular, Depression, Haematoma, Decreased Appetite, Vomiting, Nausea, Dental Caries, Gastric Haemorrhage, Hypomenorrhoea, Panic Attack, Blood Potassium Decreased, Visual Impairment, Insomnia, Platelet Count Decreased, Polymenorrhoea
Drug(s) suspected as cause:
Pegasys
Indication: Hepatitis C
Start date: 2011-07-13
Pegasys
Start date: 2011-09-14
End date: 2012-06-06
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-07-13
Ribavirin
Administration route: Oral
Start date: 2012-05-14
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07
Patient:
Reactions: Abdominal Pain, Rectal Haemorrhage, Flatulence, Anaemia, Haemorrhoids, Constipation, Faeces Discoloured, Abdominal Pain Upper, Abdominal Discomfort, Haemoglobin Decreased, Haematochezia, Fatigue, RED Blood Cell Count Decreased, Platelet Count Decreased, Memory Impairment, Blood Pressure Decreased, Lymphocyte Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180mcg, weekly
Indication: Hepatitis C
Start date: 2012-05-14
Pegasys
Dosage: 150mcg, weekly
Rebetol
Dosage: 800 mg, qd
Rebetol
Dosage: 1000 mg, qd
Indication: Hepatitis C
Start date: 2012-05-14
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-11
Possible Pegasys side effects in
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient:
Reactions: Weight Decreased, White Blood Cell Count Decreased, Abdominal Pain, Anaemia, Chills, Rash, Pyrexia, Oral Herpes, Hyperhidrosis, Fatigue, RED Blood Cell Count Decreased, Diarrhoea, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Dosage: unk
Indication: Hepatitis C
Rebetol
Dosage: 200 mg, unk
Indication: Hepatitis C
Victrelis
Dosage: 800 mg, tid
Administration route: Oral
Indication: Hepatitis C
Other drugs received by patient: Rituxan; Citalopram Hydrobromide; Vitamins (Unspecified); Neupogen; Procrit; Lisinopril
Possible Pegasys side effects in male
Reported by a physician from Spain on 2012-08-06
Patient: male, weighing 69.0 kg (151.8 pounds)
Reactions: Cholelithiasis, Pancreatitis, Platelet Count Decreased, Leukopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
BI 201335 (Hcv Protease Inhibitor)
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-16
End date: 2012-03-08
Copegus
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-16
End date: 2012-03-08
Pegasys
Indication: Hepatitis C
Start date: 2011-11-16
End date: 2012-03-08
Other drugs received by patient: Enalapril Maleate; Simvastatin
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-05
Patient:
Reactions: White Blood Cell Count Decreased, Dysgeusia, Vomiting, Nausea, RED Blood Cell Count Decreased, Malnutrition, Platelet Count Decreased, Memory Impairment, Tremor
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Ribavirin
Dosage: unk
Administration route: Oral
Victrelis
Administration route: Oral
Possible Pegasys side effects in male
Reported by a physician from United States on 2012-08-03
Patient: male
Reactions: White Blood Cell Count Decreased, Nausea, Head Injury, Pain, Blood Count Abnormal, Neck Injury, Fall, Fatigue, Limb Injury, RED Blood Cell Count Decreased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Boceprevir
Indication: Hepatitis C
Start date: 2012-04-28
Pegasys
Indication: Hepatitis C
Start date: 2012-03-30
Pegasys
Start date: 2012-05-11
Ribavirin
Start date: 2012-05-03
Ribavirin
Indication: Hepatitis C
Start date: 2012-03-30
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-02
Patient:
Reactions: Confusional State, Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 ?g, qw
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Ribavirin
Dosage: 1000 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-11-07
End date: 2012-03-13
Victrelis
Dosage: 800 mg, q8h
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-05
End date: 2012-03-13
Other drugs received by patient: Glyburide; Metformin Hydrochloride; Eprex; Nadolol; Diazepam; Spironolactone; Lasix
Possible Pegasys side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01
Patient:
Reactions: Rectal Haemorrhage, Haemorrhoids, Flatulence, Faeces Discoloured, Abdominal Pain Upper, Haemoglobin Decreased, Haematochezia, Abdominal Discomfort, Fatigue, RED Blood Cell Count Decreased, Platelet Count Decreased, Memory Impairment, Blood Pressure Decreased, Lymphocyte Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 150mcg, weekly
Pegasys
Dosage: 180mcg, weekly
Indication: Hepatitis C
Start date: 2012-05-14
Rebetol
Dosage: 1000 mg, qd
Indication: Hepatitis C
Start date: 2012-05-14
Rebetol
Dosage: 800 mg, qd
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-06-11
Possible Pegasys side effects in male
Reported by a consumer/non-health professional from United States on 2012-08-01
Patient: male
Reactions: Blindness Unilateral, Platelet Count Decreased
Drug(s) suspected as cause:
Boceprevir
Indication: Hepatitis C
End date: 2012-07-24
Pegasys
End date: 2012-07-24
Pegasys
Indication: Hepatitis C
Start date: 2012-06-12
Ribavirin
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-07-24
Possible Pegasys side effects in male
Reported by a consumer/non-health professional from China on 2012-07-27
Patient: male
Reactions: Portal Hypertension, White Blood Cell Count Decreased, Hepatic Lesion, Gastric Varices, Gastritis Haemorrhagic, Hepatomegaly, Hepatic Cyst, Gamma-Glutamyltransferase Increased, Platelet Count Decreased, Neutrophil Count Decreased, Splenomegaly, Hepatic Cirrhosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Other drugs received by patient: Chinese Patent Medicine (Unk Ingredients); Glycyrrhizin; Thymopeptide
Possible Pegasys side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: female, weighing 74.8 kg (164.7 pounds)
Reactions: Anaemia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: 180 mcg qweek sq
Indication: Hepatitis C
Start date: 2012-05-16
End date: 2012-07-01
Ribavirin
Dosage: 600 mg bid po
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-16
End date: 2012-07-01
Other drugs received by patient: Incivek
Possible Pegasys side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-25
Patient: female
Reactions: Night Sweats, Pruritus, Pneumonia, Ascites, Loss of Consciousness, RED Blood Cell Count Decreased, Insomnia, Platelet Count Decreased, Blood Pressure Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Boceprevir
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-08-19
End date: 2012-04-01
Copegus
Indication: Hepatitis C
Start date: 2011-08-19
End date: 2012-04-01
Pegasys
Indication: Hepatitis C
Start date: 2011-08-19
End date: 2012-04-01
Possible Pegasys side effects in 59 year old male
Reported by a pharmacist from United States on 2012-07-25
Patient: 59 year old male, weighing 73.5 kg (161.7 pounds)
Reactions: Contusion, Anaemia, Platelet Count Decreased
Drug(s) suspected as cause:
Pegasys
Other drugs received by patient: Incivek; Ribasphere
Possible Pegasys side effects in 62 year old male
Reported by a physician from China on 2012-07-24
Patient: 62 year old male
Reactions: White Blood Cell Count Decreased, Gastrointestinal Haemorrhage, Gingival Bleeding, Hepatic Function Abnormal, Vomiting, Anaemia, Coma, Hepatic Encephalopathy, Diarrhoea, Platelet Count Decreased, Tachypnoea, Electrolyte Imbalance, Blood Glucose Increased, Epistaxis, Influenza Like Illness
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Pegasys
Other drugs received by patient: Ribavirin
Possible Pegasys side effects in 75 year old male
Reported by a physician from Japan on 2012-07-23
Patient: 75 year old male
Reactions: Rhabdomyolysis, Henoch-Schonlein Purpura, Platelet Count Decreased, Pyrexia, Oropharyngeal Pain
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Dosage: dosage is uncertain.
Indication: Hepatitis C
Start date: 2006-12-01
Rebetol
Dosage: dosage is uncertain.
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-12-01
Possible Pegasys side effects in
Reported by a physician from United States on 2012-07-23
Patient:
Reactions: Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegasys
Rebetol
Victrelis
Dosage: unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-12-02
Page 1 Next >>
|